Press Release

Aug- 2026 -

25 August

Cision PR Newswire
0

Antengene Receives Clinical Trial Approval in Australia for Phase I ATTRACT Study of ATG-201 (CD19 x CD3 TCE) in B Cell-related Autoimmune Diseases
Read More »
25 August

Cision PR Newswire
0

Greenberg Traurig Advises Global Net Lease on $535M Modiv Industrial Acquisition
Read More »
25 August

Cision PR Newswire
0

SiMa.ai and AVerMedia to Showcase Integrated Drone AI Solution at August 27, 2026 Drone Seminar
Read More »
25 August

Cision PR Newswire
0

AGNTCon + MCPCon Japan to Convene Builders Advancing Production-Ready Agentic AI
Read More »
25 August

Cision PR Newswire
0

CHT Security Receives Frost & Sullivan’s 2026 Taiwan Company of the Year Recognition for Excellence in Cybersecurity Services
Read More »
25 August

Cision PR Newswire
0

SCX.ai (ASX: SCX) Strategic Partnership With Global AI Leader DDN to Power Australia’s Largest Sovereign AI Inferencing Cloud
Read More »
25 August

Business Wire

Singapore CFO Business Optimism Falls 34 Points, the Sharpest Decline Across Nine Markets
Read More »
24 August

Cision PR Newswire
0

FDA approves IMAAVY® (nipocalimab-aahu) as first-ever treatment for warm autoimmune hemolytic anemia (wAIHA), representing a landmark advancement for patients
Read More »
24 August

Cision PR Newswire
0

Tuya Reports Second Quarter 2026 Unaudited Financial Results
Read More »
24 August

Cision PR Newswire
0

Readout – Prime Minister Carney speaks with Chancellor of Germany Friedrich Merz
Read More »

Previous page Next page